Showing results (1851-1860 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|March 14, 2019
Correction to: vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality IssuesTomas Bergvall, G Niklas Norén, Marie LindquistDrug Safety|December 21, 2021
Patient Safety Incidents Related to the Use of Parenteral Nutrition in All Patient Groups: A Systematic Scoping ReviewPriya Mistry, Rebecca Heather Smith, Andy FoxDrug Safety|December 20, 2021
RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and ManageabilityErnest Nadal, Hidehito Horinouchi, Jin-Yuan Shih, et al.Drug Safety|March 15, 2014
Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibitionMinjie Lin, Shuiping Zhao, Li Shen, et al.Drug Safety|March 5, 2021
Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-AnalysisJuan S Lasa, Pablo A Olivera, Stefanos Bonovas, et al.Drug Safety|April 12, 2017
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-AnalysisAngel Y S Wong, Esther W Chan, Shweta Anand, et al.Drug Safety|June 19, 2008
Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in ItalyDomenico Motola, Antonio Vargiu, Roberto Leone, et al.Drug Safety|July 6, 2012
Hearing impairment associated with oral terbinafine use: a case series and case/non-case analysis in the Netherlands Pharmacovigilance Centre Lareb database and VigiBase™Joep H G Scholl, Eugene P van PuijenbroekDrug Safety|August 15, 1998
Comparative tolerability profile of hypertensive crisis treatmentsE Grossman, A N Ironi, F H MesserliDrug Safety|August 15, 1998
Comparative tolerability of drug therapies used to treat incontinence and enuresisR G Owens, M M KarramPageof 309